Current Analysis of Skeletal Phenotypes in Down Syndrome

Area of Science:

• Genetics
• Orthopedics
• Endocrinology

Background:

• Down syndrome (DS), caused by trisomy 21 (Ts21), is associated with significant skeletal deficits.
• These deficits include shortened stature, reduced bone mineral density, and a higher risk of early-onset osteoporosis.
• The precise genetic or cellular origins of these skeletal phenotypes in DS remain incompletely understood.

Purpose of the Study:

• To investigate the nature and origins of skeletal deficits in Down syndrome.
• To explore the role of trisomy 21 in altering skeletal development, bone homeostasis, and bone strength.
• To identify potential sex-specific differences in skeletal phenotypes within the DS population.

Main Methods:

• Analysis of skeletal development and morphology in individuals with Ts21.
• Investigation of cellular and molecular pathways affected by trisomic gene overexpression.
• Comparative studies examining age-related bone loss and bone quality in DS versus typically developing individuals.
• Assessment of sex-specific alterations in bone accrual, remodeling, and homeostasis.

Main Results:

• Down syndrome is characterized by sexual dimorphism in skeletal deficits and their onset.
• Age-related bone loss occurs earlier in individuals with DS compared to the general population.
• Overexpression of trisomic genes leads to perturbations in skeletal quality via altered cellular and molecular pathways.
• Sex-specific changes in developmental pathways exacerbate bone loss and increase risks for osteopenia, osteoporosis, and fractures in DS.

Conclusions:

• Trisomy 21 significantly impacts skeletal development and homeostasis, leading to various deficits.
• Sex-specific alterations in critical pathways, compounded by aging, contribute to increased skeletal fragility in Down syndrome.
• Understanding these complex mechanisms is crucial for developing targeted interventions to mitigate skeletal complications in DS.